Thursday, June 21, 2018
Clinical Trial for EPP! Participants are needed for participation in a Phase II clinical trial to study an investigational drug for EPP
Drug for EPP. CONTACT THE APF ON 1-866-APF-3635 or email firstname.lastname@example.org to learn
An oral investigational drug has been developed with the potential to increase sunlight duration and tolerance in
individuals with EPP. This phase II clinical trial is needed to understand if the investigational drug works and to
ensure that it is safe. The study duration is 24 weeks including follow-up.
You must be age 18-70 to participate
and have a confirmed diagnosis of EPP. All travel is included and will be arranged by a concierge service.
Contact the APF today – trial spaces will fill quickly! 1-866-APF-3635.
"Remember...Research is the key to YOUR cure!"
Each Step Toward Finding an Effective Treatment is Important!
CME AND ADDITIONAL RESOURCES Continuing Medical Education (CME) Please visit this area again soon for upcoming CME opportunities. ...
Erythropoietic Protoporphyria What is erythropoietic protoporphyria? The word ‘erythropoietic’ means associated with red blood cells (‘...
#PAW2018 This year, each day we will bring you a member story of each type, a Medical Fact on each type, Medications approved ...